Eton Pharmaceuticals (ETON)
NASDAQ:ETON
Want to see ETON full AI Analyst Report?
Eton Pharmaceuticals (ETON) Ownership Overview
15.43% Insiders
6.86% Mutual Funds
37.13% Other Institutional Investors
8.23% ETFs
32.36% Public Companies and
Individual Investors
The ownership structure of Eton Pharmaceuticals (ETON) stock is a mix of institutional, retail, and individual investors. Approximately 52.22% of the company’s stock is owned by Institutional Investors, 15.43% is owned by Insiders, and 32.36% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 29, 2026 | xxxxxxxxxxxxx | $3825717 | |
May 27, 2026 | xxxxxxxxxxxxx | $3229717 | |
Feb 05, 2026 | xxxxxxxxxxxxx | $132600 | |
Aug 20, 2025 | xxxxxxxxxxxxx | $673714 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2025 | xxxxxxxxxxxxx | $4212851 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,855,000 | Insider | 10.42% | 82,509,500 | |
| 1,139,729 | Institution | 4.16% | 32,938,168 | |
| 983,182 | Institution | 3.59% | 28,413,960 | |
| 973,187 | Institution | 3.55% | 28,125,104 | |
| 833,694 | Insider | 3.04% | 24,093,757 | |
| 267,647 | Institution | 0.98% | 7,734,998 | |
| 224,300 | Insider | 0.82% | 6,482,270 | |
| 218,784 | Institution | 0.80% | 6,322,858 | |
| 213,420 | Insider | 0.78% | 6,167,838 | |
| 170,699 | Institution | 0.62% | 4,933,201 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 973,187 | Institution | 3.55% | 28,125,104 | |
| 267,647 | Institution | 0.98% | 7,734,998 | |
| 218,784 | Institution | 0.80% | 6,322,858 | |
| 152,734 | Institution | 0.56% | 4,414,013 | |
| 77,190 | Institution | 0.28% | 2,230,791 | |
| 58,480 | Institution | 0.21% | 1,690,072 | |
| 19,636 | Institution | 0.07% | 567,480 | |
| 17,105 | Institution | 0.06% | 494,335 | |
| 11,836 | Institution | 0.04% | 342,060 | |
| 11,729 | Institution | 0.04% | 338,968 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 715,024 | Institution | 2.61% | 17,246,379 | |
| 597,738 | Institution | 2.18% | 17,274,628 | |
| 259,725 | Institution | 0.95% | 6,264,567 | |
| 212,266 | Institution | 0.77% | 6,134,487 | |
| 129,441 | Institution | 0.47% | 3,122,117 | |
| 66,419 | Institution | 0.24% | 1,919,509 | |
| 53,589 | Institution | 0.20% | 1,548,722 | |
| 27,208 | Institution | 0.10% | 786,311 | |
| 23,373 | Institution | 0.09% | 563,757 | |
| 21,443 | Institution | 0.08% | 619,703 |
FAQ
Who Owns Eton Pharmaceuticals (ETON)?
According to the latest TipRanks data, approximately 37.13% of the company's stock is held by institutional investors, 15.43% is held by insiders, and 32.36% is held by retail investors.
What percentage of Eton Pharmaceuticals (ETON) stock is held by institutional investors?
According to the latest TipRanks data, approximately 37.13% of Eton Pharmaceuticals (ETON) stock is held by institutional investors.
What percentage of Eton Pharmaceuticals (ETON) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.36% of Eton Pharmaceuticals (ETON) stock is held by retail investors.
Who owns the most shares of Eton Pharmaceuticals (ETON)?
Opaleye Management Inc. owns the most shares of Eton Pharmaceuticals (ETON).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.